Millennium Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.7M Buy
3,120,339
+980,748
+46% +$4.63M 0.01% 1340
2025
Q1
$9.82M Buy
2,139,591
+1,470,898
+220% +$6.75M 0.01% 1542
2024
Q4
$3.2M Buy
668,693
+269,183
+67% +$1.29M ﹤0.01% 2262
2024
Q3
$1.87M Buy
399,510
+383,273
+2,360% +$1.8M ﹤0.01% 2590
2024
Q2
$91.7K Sell
16,237
-416,565
-96% -$2.35M ﹤0.01% 3718
2024
Q1
$1.78M Sell
432,802
-565,490
-57% -$2.32M ﹤0.01% 2665
2023
Q4
$4.21M Sell
998,292
-1,017,023
-50% -$4.29M ﹤0.01% 2002
2023
Q3
$8.71M Buy
2,015,315
+1,435,541
+248% +$6.2M ﹤0.01% 1516
2023
Q2
$3.82M Sell
579,774
-1,181,954
-67% -$7.79M ﹤0.01% 2114
2023
Q1
$12M Sell
1,761,728
-22,017
-1% -$149K 0.01% 1296
2022
Q4
$13.2M Buy
1,783,745
+1,633,788
+1,090% +$12.1M 0.01% 1334
2022
Q3
$1.48M Sell
149,957
-1,040,453
-87% -$10.3M ﹤0.01% 3085
2022
Q2
$13M Buy
1,190,410
+356,418
+43% +$3.88M 0.01% 1269
2022
Q1
$9.43M Buy
833,992
+394,318
+90% +$4.46M 0.01% 1668
2021
Q4
$6.9M Sell
439,674
-167,070
-28% -$2.62M ﹤0.01% 1947
2021
Q3
$10.4M Buy
606,744
+351,137
+137% +$6.02M 0.01% 1456
2021
Q2
$5.5M Sell
255,607
-461,108
-64% -$9.92M ﹤0.01% 2033
2021
Q1
$10.8M Buy
716,715
+73,005
+11% +$1.1M 0.01% 1305
2020
Q4
$8.46M Buy
643,710
+476,053
+284% +$6.26M 0.01% 1485
2020
Q3
$1.62K Buy
+167,657
New +$1.62K ﹤0.01% 2168
2020
Q2
Sell
-280,178
Closed -$2.9M 3777
2020
Q1
$2.9M Buy
280,178
+266,565
+1,958% +$2.76M 0.01% 1412
2019
Q4
$223K Sell
13,613
-448,362
-97% -$7.34M ﹤0.01% 3116
2019
Q3
$6.14M Sell
461,975
-60,350
-12% -$801K 0.01% 1332
2019
Q2
$7.36M Sell
522,325
-135,697
-21% -$1.91M 0.01% 1254
2019
Q1
$12.1M Buy
658,022
+72,158
+12% +$1.33M 0.02% 962
2018
Q4
$15.3M Buy
585,864
+293,273
+100% +$7.66M 0.02% 773
2018
Q3
$6.72M Sell
292,591
-97,811
-25% -$2.24M 0.01% 1416
2018
Q2
$7.44M Sell
390,402
-605,873
-61% -$11.5M 0.01% 1378
2018
Q1
$16.8M Sell
996,275
-131,290
-12% -$2.21M 0.02% 940
2017
Q4
$17.1M Sell
1,127,565
-313,196
-22% -$4.76M 0.02% 965
2017
Q3
$25.8M Buy
1,440,761
+1,006,282
+232% +$18M 0.04% 624
2017
Q2
$7.08M Sell
434,479
-134,864
-24% -$2.2M 0.01% 1167
2017
Q1
$7.97M Sell
569,343
-451,828
-44% -$6.33M 0.01% 1071
2016
Q4
$16.3M Sell
1,021,171
-660,510
-39% -$10.5M 0.03% 652
2016
Q3
$28M Buy
1,681,681
+1,244,770
+285% +$20.7M 0.05% 426
2016
Q2
$4.89M Sell
436,911
-1,731,825
-80% -$19.4M 0.01% 1170
2016
Q1
$18.1M Buy
2,168,736
+632,966
+41% +$5.29M 0.05% 512
2015
Q4
$14.3M Sell
1,535,770
-259,698
-14% -$2.42M 0.03% 701
2015
Q3
$20.3M Buy
1,795,468
+711,709
+66% +$8.03M 0.04% 541
2015
Q2
$13.8M Sell
1,083,759
-515,403
-32% -$6.54M 0.03% 766
2015
Q1
$14.9M Buy
1,599,162
+786,392
+97% +$7.31M 0.03% 798
2014
Q4
$11.6M Buy
812,770
+193,191
+31% +$2.77M 0.02% 853
2014
Q3
$6.43M Buy
619,579
+359,372
+138% +$3.73M 0.02% 1046
2014
Q2
$4.21M Buy
260,207
+60,207
+30% +$974K 0.01% 1164
2014
Q1
$3.25M Sell
200,000
-678,530
-77% -$11M 0.01% 1222
2013
Q4
$10.9M Sell
878,530
-451,090
-34% -$5.6M 0.03% 559
2013
Q3
$14.6M Buy
1,329,620
+780,722
+142% +$8.55M 0.05% 448
2013
Q2
$4.44M Buy
+548,898
New +$4.44M 0.01% 924